BDX vs IRMD
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. IRMD: IRADIMED CORP provides specialized MRI-compatible medical devices, specifically infusion pumps and patient monitoring systems, engineered for safe operation within magnetic resonance imaging environments.
Side-by-side fundamentals
| Metric | BDX | IRMD | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $165.62 | $90.86 | |
| Market cap as of 2026-08-03 | $45.6B | $1.2B | |
| P/E as of 2026-08-03 | 42.05 | 49.51 | BDX lower |
| PEG as of 2026-08-03 | -24.04 | 4.78 | BDX lower |
| Net margin as of 2026-08-03 | +5.3% | +27.4% | IRMD higher |
| Gross margin as of 2026-08-03 | +47.0% | +76.8% | IRMD higher |
| Operating margin as of 2026-08-03 | +10.2% | +32.4% | IRMD higher |
| ROE as of 2026-08-03 | +4.5% | +24.5% | IRMD higher |
| ROA as of 2026-08-03 | +2.1% | +21.3% | IRMD higher |
| Debt / equity as of 2026-08-03 | 0.72 | 0.00 | IRMD lower |
| Revenue growth (YoY) as of 2026-08-03 | +2.4% | +14.8% | IRMD higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | +16.3% | IRMD higher |
| Dividend yield as of 2026-08-03 | +2.5% | +0.9% | BDX higher |
| Dividend streak (yrs) SEC XBRL | 5 | 1 | BDX higher |
| Beta as of 2026-08-03 | 0.44 | 0.76 | |
| 1-year return as of 2026-07-31 close | +18.2% | +55.7% | IRMD higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.